January 15, 2014
RESEARCH TRIANGLE PARK, N.C. - Tuesday, January 7th 2014 [ME NewsWire]
(BUSINESS WIRE)-- Quintiles CEO Tom Pike will present at the 2014 J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014 in San Francisco at the Westin St. Francis Hotel.
The Quintiles presentation will begin at 9 a.m. PST. Investors may access a live audio webcast of the presentation through the Quintiles Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Contacts
Quintiles
Phil Bridges
Media Relations
+ 1-919-998-1653 (office)
+ 1-919-457-6347 (mobile)
phil.bridges@quintiles.com
Karl Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com
Permalink: http://me-newswire.net/news/9650/en
RESEARCH TRIANGLE PARK, N.C. - Tuesday, January 7th 2014 [ME NewsWire]
(BUSINESS WIRE)-- Quintiles CEO Tom Pike will present at the 2014 J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014 in San Francisco at the Westin St. Francis Hotel.
The Quintiles presentation will begin at 9 a.m. PST. Investors may access a live audio webcast of the presentation through the Quintiles Investor Relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE:Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com
Contacts
Quintiles
Phil Bridges
Media Relations
+ 1-919-998-1653 (office)
+ 1-919-457-6347 (mobile)
phil.bridges@quintiles.com
Karl Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com
Permalink: http://me-newswire.net/news/9650/en
No comments:
Post a Comment